PIAS1 and non-small cell lung carcinoma: PIAS1-induced SUMOylation of PML facilitates its degradation and thus promotes NSCLC progression, while vascular endothelial growth factor receptor 2 (VEGFR2) SUMOylation inhibits angiogenesis signaling pathway in NSCLC [23, 24].